Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs
Open accessThe DOI matches its Crossref record; 159 of the 161 references it cites were found in a registry or an index.
Abstract
HIV-infected drug users have increased age-matched morbidity and mortality compared with HIV-infected people who do not use drugs. Substance-use disorders negatively affect the health of HIV-infected drug users, who also have frequent medical and psychiatric comorbidities that complicate HIV treatment and prevention. Evidence-based treatments are available for the management of substance-use disorders, mental illness, HIV and other infectious complications such as viral hepatitis and tuberculosis, and many non-HIV-associated comorbidities. Tuberculosis co-infection in HIV-infected drug users, including disease caused by drug-resistant strains, is acquired and transmitted as a consequence of inadequate prescription of antiretroviral therapy, poor adherence, and repeated interfaces with congregate settings such as prisons. Medication-assisted therapies provide the strongest evidence for HIV treatment and prevention efforts, yet are often not available where they are needed most. Antiretroviral therapy, when prescribed and adherence is at an optimum, improves health-related outcomes for HIV infection and many of its comorbidities, including tuberculosis, viral hepatitis, and renal and cardiovascular disease. Simultaneous clinical management of multiple comorbidities in HIV-infected drug users might result in complex pharmacokinetic drug interactions that must be adequately addressed. Moreover, interventions to improve adherence to treatment, including integration of health services delivery, are needed. Multifaceted, interdisciplinary approaches are urgently needed to achieve parity in health outcomes in HIV-infected drug users.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Substance use can form a high-mortality link between mental and physical illness. 13”
From The Hotel Study—Clinical and Health Service Effectiveness in a Cohort of Homeless or Marginally Housed Persons (2017) · cites this paper as [13]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub4 · Cited by 2,274
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
Mattick, R. P., Breen, C., Kimber, J., & Davoli, M. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002209.pub2 · Cited by 1,654
Kaplan, J. E., Benson, C., Holmes, K. K., Brooks, J. T., Pau, A., & Masur, H. (2009) · PsycEXTRA Dataset · doi:10.1037/e537722009-001 · Cited by 1,343
Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
Opioid antagonists for alcohol dependence
Srisurapanont, M., & Jarusuraisin, N. (2002) · The Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001867 · Cited by 764
Timing of Initiation of Antiretroviral Drugs during Tuberculosis Therapy
Abdool Karim, S. S., Naidoo, K., Grobler, A., Padayatchi, N., Baxter, C., Gray, A., Gengiah, T., Nair, G., Bamber, S., Singh, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0905848 · Cited by 666
Self-citationSocial Context, Sexual Networks, and Racial Disparities in Rates of Sexually Transmitted Infections
Adimora, A. A., & Schoenbach, V. J. (2005) · The Journal of Infectious Diseases · doi:10.1086/425280 · Cited by 650
Directly observed therapy for treating tuberculosis
Karumbi, J., & Garner, P. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003343.pub4 · Cited by 644
Research works printed but not linked: 4
- Lewden C, Mortality Working Group of COHERE. Time with CD4 cell count above 500 cells/mm3 allows HIV-infected men, but not women, to reach similar mortality rates to those of the general population: a seven-year analysis. 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA, USA; Feb 16–19, 2010. Abstract 527.
- Lobmaier, 2008, Sustained-release naltrexone for opioid dependence, Cochrane Database Syst Rev, 2
- Samandari T, Mosimaneotsile B, Agizew T, et al. Randomized, placebo-controlled trial of 6 vs 36 months isoniazid TB preventive therapy for HIV-infected adults in Botswana. 17th Conference on Retroviruses and Opportunistic Infections; San Francisco, CA, USA; Feb 16–19, 2010. Abstract 104LB.
- Arnsten JH, Berg KM, Mouriz J, Li X, Goldberg U, Goldstein H. Final results from a 6-month, randomized controlled trial of directly observed therapy delivered in methadone clinics. Fourth International Conference on HIV Treatment Adherence; Miami, FL, USA; April 5–7, 2009. Abstract 030.
Cited by
Global patterns of opioid use and dependence: harms to populations, interventions, and future action
Degenhardt, L., Grebely, J., Stone, J., Hickman, M., Vickerman, P., Marshall, B. D. L., Bruneau, J., Altice, F. L., Henderson, G., Rahimi-Movaghar, A., et al. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32229-9 · Cited by 832
Self-citationThompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Self-citationPublic Health and the Epidemic of Incarceration
Dumont, D. M., Brockmann, B., Dickman, S., Alexander, N., & Rich, J. D. (2012) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-031811-124614 · Cited by 426
Wolfe, D., Carrieri, M. P., & Shepard, D. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60832-x · Cited by 418
Altice, F. L., Azbel, L., Stone, J., Brooks-Pollock, E., Smyrnov, P., Dvoriak, S., Taxman, F. S., El-Bassel, N., Martin, N. K., Booth, R., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30856-x · Cited by 277
Self-citation
Metadata
- Authors
- Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H.
- Affiliations
- Yale University (US)
- University of Malaya (MY)
- Instituto de Salud Carlos III (ES)
- Universidade Federal do Rio de Janeiro (BR)
- Corresponding author
- Altice, Frederick L
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2010-07
- Volume
- 376
- Issue
- 9738
- Pages
- 367-387
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- PMC
- PMC4855280
- OpenAlex
- W2001592123
- Cited by
- 504
- References
- 161
- Citations by year
- 2026: 11 · 2025: 17 · 2024: 27 · 2023: 20 · 2022: 15 · 2021: 34 · 2020: 31 · 2019: 25 · 2018: 38 · 2017: 45 · 2016: 40 · 2015: 42 · 2014: 35 · 2013: 54 · 2012: 36
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Drug Abuse (R01DA025932, K24DA017072, R01DA025943, R01DA017059, R01DA013805)
- Topics
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Keywords
- HIV, drug users, substance use disorders, psychiatric comorbidity, comorbidities, tuberculosis co-infection, drug-resistant tuberculosis, viral hepatitis, antiretroviral therapy, medication adherence, medication-assisted treatment, pharmacokinetic interactions, integrated care, HIV prevention
- MeSH terms
- Antitubercular Agents, Antiviral Agents, Bacterial Infections, Mental Disorders, Criminal Law, Drug Interactions, Hepatitis, Viral, Human, Humans, Narcotics, Prisoners, Antipsychotic Agents, Tuberculosis, HIV Infections, Comorbidity, AIDS-Related Opportunistic Infections, Evidence-Based Medicine, Anti-HIV Agents, Substance-Related Disorders, Drug Resistance, Bacterial, Medication Adherence
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. https://app.cochat.ai/papers/10.1016/s0140-6736(10)60829-x
- The paper
- Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet. https://doi.org/10.1016/s0140-6736(10)60829-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.